These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 17699817

  • 1. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM, Cevasco M, Rosenthal MB.
    N Engl J Med; 2007 Aug 16; 357(7):673-81. PubMed ID: 17699817
    [Abstract] [Full Text] [Related]

  • 2. Medical Marketing in the United States, 1997-2016.
    Schwartz LM, Woloshin S.
    JAMA; 2019 Jan 01; 321(1):80-96. PubMed ID: 30620375
    [Abstract] [Full Text] [Related]

  • 3. Promotion of prescription drugs to consumers.
    Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM.
    N Engl J Med; 2002 Feb 14; 346(7):498-505. PubMed ID: 11844852
    [Abstract] [Full Text] [Related]

  • 4. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H.
    Int J Health Policy Manag; 2015 Aug 25; 4(12):813-21. PubMed ID: 26673465
    [Abstract] [Full Text] [Related]

  • 5. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.
    DiStefano MJ, Markell JM, Doherty CC, Alexander GC, Anderson GF.
    JAMA; 2023 Feb 07; 329(5):386-392. PubMed ID: 36749334
    [Abstract] [Full Text] [Related]

  • 6. The federal regulation of prescription drug advertising and promotion.
    Kessler DA, Pines WL.
    JAMA; 1990 Nov 14; 264(18):2409-15. PubMed ID: 2231998
    [Abstract] [Full Text] [Related]

  • 7. A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation.
    Li S, Gibbs I.
    J Pharm Pharm Sci; 2021 Nov 14; 24():381-389. PubMed ID: 34314671
    [Abstract] [Full Text] [Related]

  • 8. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL, Katz KA.
    Br J Dermatol; 2006 May 14; 154(5):950-8. PubMed ID: 16634900
    [Abstract] [Full Text] [Related]

  • 9. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT, Duhamel LM, Dievler A, Price R.
    Health Aff (Millwood); 2003 May 14; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
    Nguyen D, Seoane-Vazquez E, Rodriguez-Monguio R, Montagne M.
    BMC Health Serv Res; 2013 Jan 22; 13():27. PubMed ID: 23339419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mackey TK.
    Int J Health Policy Manag; 2016 Feb 03; 5(4):271-4. PubMed ID: 27239871
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD.
    Pharmacoeconomics; 2001 Feb 03; 19(2):109-19. PubMed ID: 11284378
    [Abstract] [Full Text] [Related]

  • 17. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.
    Mintzes B, Morgan S, Wright JM.
    PLoS One; 2009 May 27; 4(5):e5699. PubMed ID: 19479084
    [Abstract] [Full Text] [Related]

  • 18. The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand.
    Norey E, Simone TM, Mousa SA.
    Appl Health Econ Health Policy; 2008 May 27; 6(2-3):93-102. PubMed ID: 19231903
    [Abstract] [Full Text] [Related]

  • 19. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.
    Ma J, Stafford RS, Cockburn IM, Finkelstein SN.
    Clin Ther; 2003 May 27; 25(5):1503-17. PubMed ID: 12867225
    [Abstract] [Full Text] [Related]

  • 20. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Rollins BL.
    Int J Health Policy Manag; 2016 Feb 10; 5(4):287-8. PubMed ID: 27239875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.